Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Rnai as an experimental and therapeutic tool to study and regulate physiological and disease processes.

Dillon CP, Sandy P, Nencioni A, Kissler S, Rubinson DA, Van Parijs L.

Annu Rev Physiol. 2005;67:147-73. Review.

PMID:
15709955
2.

Therapeutic potential of RNAi in metabolic diseases.

Rondinone CM.

Biotechniques. 2006 Apr;Suppl:31-6. Review.

3.

Minireview: ribonucleic acid interference for the identification of new targets for the treatment of metabolic diseases.

Rondinone CM.

Endocrinology. 2006 Jun;147(6):2650-6. Epub 2006 Mar 23. Review.

PMID:
16556759
4.

RNAi therapeutics for CNS disorders.

Boudreau RL, Davidson BL.

Brain Res. 2010 Jun 18;1338:112-21. doi: 10.1016/j.brainres.2010.03.038. Epub 2010 Mar 20. Review.

PMID:
20307511
5.

RNA interference and its current application in mammals.

Shen WG.

Chin Med J (Engl). 2004 Jul;117(7):1084-91. Review.

PMID:
15265387
6.

RNA interference-based therapeutics for shrimp viral diseases.

Krishnan P, Gireesh-Babu P, Rajendran KV, Chaudhari A.

Dis Aquat Organ. 2009 Nov 9;86(3):263-72. doi: 10.3354/dao02126. Review.

7.

Therapeutic RNA interference for neurodegenerative diseases: From promise to progress.

Gonzalez-Alegre P.

Pharmacol Ther. 2007 Apr;114(1):34-55. Epub 2007 Jan 25. Review.

PMID:
17316816
8.

RNA interference for therapy in the vascular endothelium.

Kaufmann J, Ahrens K, Santel A.

Microvasc Res. 2010 Sep;80(2):286-93. doi: 10.1016/j.mvr.2010.02.002. Epub 2010 Feb 6. Review.

PMID:
20144624
9.

The therapeutic potential of RNA interference.

Uprichard SL.

FEBS Lett. 2005 Oct 31;579(26):5996-6007. Epub 2005 Aug 15. Review.

10.

RNA interference in neuroscience: progress and challenges.

Miller VM, Paulson HL, Gonzalez-Alegre P.

Cell Mol Neurobiol. 2005 Dec;25(8):1195-207. Review.

PMID:
16388332
11.

RNA interference: an emerging generation of biologicals.

Shrivastava N, Srivastava A.

Biotechnol J. 2008 Mar;3(3):339-53. doi: 10.1002/biot.200700215. Review.

PMID:
18320564
12.

Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.

DeVincenzo JP.

Early Hum Dev. 2009 Oct;85(10 Suppl):S31-5. doi: 10.1016/j.earlhumdev.2009.08.013. Epub 2009 Oct 14.

PMID:
19833462
13.

RNA interference: new therapeutics in allergic diseases.

Lee CC, Chiang BL.

Curr Gene Ther. 2008 Aug;8(4):236-46. Review.

PMID:
18691019
14.

Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression.

He S, Zhang D, Cheng F, Gong F, Guo Y.

Mol Biol Rep. 2009 Nov;36(8):2153-63. doi: 10.1007/s11033-008-9429-7. Epub 2009 Jan 1. Review.

PMID:
19117119
15.

Immunological research using RNA interference technology.

Mao CP, Lin YY, Hung CF, Wu TC.

Immunology. 2007 Jul;121(3):295-307. Epub 2007 Apr 12. Review.

16.

RNA interference: its use as antiviral therapy.

Haasnoot J, Berkhout B.

Handb Exp Pharmacol. 2006;(173):117-50. Review.

PMID:
16594614
17.

The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.

DeVincenzo JP.

Antivir Ther. 2012;17(1 Pt B):213-25. doi: 10.3851/IMP2064. Epub 2012 Feb 3. Review.

PMID:
22311654
18.

[RNA interference: from origins to a novel tool for gene silencing].

Ortiz-Quintero B.

Rev Invest Clin. 2009 Sep-Oct;61(5):412-27. Review. Spanish.

PMID:
20184102
19.

RNAi-based therapeutics-current status, challenges and prospects.

Tiemann K, Rossi JJ.

EMBO Mol Med. 2009 Jun;1(3):142-51. doi: 10.1002/emmm.200900023. Review.

20.

Potential application of RNAi for understanding and therapy of neurodegenerative diseases.

Schwartz EI.

Front Biosci (Landmark Ed). 2009 Jan 1;14:297-320. Review.

PMID:
19273068

Supplemental Content

Support Center